Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Verastem (VSTM) EBITDA (2018 - 2025)

Verastem (VSTM) has 8 years of EBITDA data on record, last reported at -$38.4 million in Q4 2025.

  • For Q4 2025, EBITDA rose 40.48% year-over-year to -$38.4 million; the TTM value through Dec 2025 reached -$204.2 million, down 56.33%, while the annual FY2025 figure was -$204.2 million, 56.33% down from the prior year.
  • EBITDA reached -$38.4 million in Q4 2025 per VSTM's latest filing, up from -$95.8 million in the prior quarter.
  • Across five years, EBITDA topped out at -$8.3 million in Q2 2024 and bottomed at -$95.8 million in Q3 2025.
  • Average EBITDA over 5 years is -$28.4 million, with a median of -$22.4 million recorded in 2021.
  • Peak YoY movement for EBITDA: soared 66.02% in 2024, then tumbled 299.6% in 2025.
  • A 5-year view of EBITDA shows it stood at -$16.5 million in 2021, then decreased by 1.79% to -$16.8 million in 2022, then tumbled by 63.42% to -$27.4 million in 2023, then crashed by 135.55% to -$64.6 million in 2024, then soared by 40.48% to -$38.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were -$38.4 million in Q4 2025, -$95.8 million in Q3 2025, and -$24.6 million in Q2 2025.